Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
Details for Australian Patent Application No. 2002359714 (hide)
International Classifications
Event Publications
3 April 2003 Complete Application Filed
Priority application(s): 60/341,382 18.12.01 US
28 August 2003 Application Open to Public Inspection
Published as AU-B-2002359714
21 December 2006 Application Accepted
Published as AU-B-2002359714
19 April 2007 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002359713-Spectroscopic method of determining an analyte concentration in a sample
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser